Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions - Takeaways - MDSpire

Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions

  • By

  • Arya Haj Mirzaian

  • Nooshin Abbasi

  • Avinash R. Kambadakone

  • Ronilda Lacson

  • Yasmin G. Hernandez-Barco

  • David X. Jin

  • Kunal Jajoo

  • David W. Bates

  • Ramin Khorasani

  • May 20, 2026

  • 0 min

Share

  • 1

    Pancreatic cancer has a low 5-year survival rate, emphasizing the need for early detection of the disease and its precursors.

  • 2

    Pancreatic cystic lesions (PCLs) are common precursors of pancreatic cancer, found in up to 50% of the general population.

  • 3

    Management of low-risk PCLs is challenging due to their diverse biological behavior and the lack of strong evidence-based guidelines.

  • 4

    Current practices for low-risk PCLs vary significantly among clinicians, leading to uncertainty in patient management.

  • 5

    The study aims to assess the long-term incidence of pancreatic cancer in patients with low-risk PCLs using a large retrospective cohort.

Original Source(s)

Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions

  • by Arya Haj Mirzaian, Nooshin Abbasi, Avinash R. Kambadakone, Ronilda Lacson, Yasmin G. Hernandez-Barco, David X. Jin, Kunal Jajoo, David W. Bates, Ramin Khorasani

  • May 20, 2026

Related Content

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

High-grade astrocytoma with piloid features: a case report of comprehensive management

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”